NeuroDex
PrivateLast Round
Grant
Nov 6, 2024
Total Funding Raised
$1.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuroDex operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Grant round in November 2024.
NeuroDex is a biotechnology company that has developed a blood-based diagnostics platform designed to diagnose neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroDex Comparables
Compare NeuroDex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoSomiX, Inc. | 90% | |
| C₂N Diagnostics | 79% | |
| Amydis, Inc. | 78% |
For institutional investors. Book with your work email.
NeuroDex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2024 | ||||
| Grant | Nov 1, 2024 | ||||
| Grant | Oct 31, 2023 | ||||
| Grant | Mar 28, 2023 | ||||
| Grant | Jan 26, 2023 | ||||
Seed | Aug 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroDex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Target ALS | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| ICV Venture Engineering Fund I | Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 34% MoM.
- Jul 29, 2026
Monthly visitors increased 56% MoM.
For institutional investors. Book with your work email.
NeuroDex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroDex's valuation, stock price, and market status.
Is NeuroDex a public or private company?
NeuroDex is a private company.
What is the current stock price of NeuroDex?
NeuroDex is a private company, so its shares have no public market price. Caplight tracks NeuroDex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroDex worth (valuation)?
Valuation information for NeuroDex is not publicly available.
Can I buy NeuroDex stock?
NeuroDex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroDex's last funding round?
NeuroDex's most recent funding round was Grant on November 6, 2024.
Who are the main investors in NeuroDex?
Key investors in NeuroDex include ICV Venture Engineering Fund I.
Will NeuroDex IPO soon?
No public IPO plans have been announced for NeuroDex.
How can I track NeuroDex secondary market activity?
Caplight tracks bids, offers, and trades in NeuroDex's shares on secondary markets.